APPENDIX CANCER
Clinical trials for APPENDIX CANCER explained in plain language.
Never miss a new study
Get alerted when new APPENDIX CANCER trials appear
Sign up with your email to follow new studies for APPENDIX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: CBX-12 drug trial begins
Disease control CompletedThis study tested a new drug called CBX-12 in 69 adults with advanced solid tumors (like ovarian, lung, or breast cancer) that had stopped responding to standard treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The study was completed, but res…
Matched conditions: APPENDIX CANCER
Phase: PHASE1, PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:26 UTC
-
Smart dosing algorithm keeps chemo on track
Disease control CompletedThis study tested a new computer-based tool that helps doctors adjust chemotherapy doses for people with cancers of the digestive system (like colorectal or stomach cancer). The goal was to reduce unplanned treatment delays caused by low blood cell counts. 52 adults receiving FOL…
Matched conditions: APPENDIX CANCER
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated May 17, 2026 00:25 UTC